| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9253738 | Journal of Hepatology | 2005 | 7 Pages |
Abstract
Emtricitabine was well tolerated and demonstrated a potent antiviral response for up to 2 years in patients with chronic hepatitis B infection. Based on these data, 200Â mg emtricitabine once daily was chosen as the optimal dose for future hepatitis B studies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Robert G. Gish, Huy Trinh, Nancy Leung, Francis K.L. Chan, Michael W. Fried, Teresa L. Wright, Chia Wang, Jane Anderson, Elsa Mondou, Andrea Snow, Jeff Sorbel, Franck Rousseau, Lawrence Corey,